According to GoodRx's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.17. At the end of 2024 the company had a P/S ratio of 2.22.
Year | P/S ratio | Change |
---|---|---|
2024 | 2.22 | -38.72% |
2023 | 3.63 | 50.58% |
2022 | 2.41 | -86.23% |
2021 | 17.5 | -39% |
2020 | 28.7 |